Resistance to echinocandins is primarily driven by mutations in the FKS genes, which encode the catalytic subunit of β-(1,3)-D-glucan synthase. These mutations reduce drug binding, rendering the antifungal less effective. Monitoring these resistance patterns is crucial for maintaining the efficacy of echinocandins.
